Phosphoramidites

Fmoc-PNA-M(Bhoc)-OH

Description: Fmoc-PNA-M(Bhoc)-OH is a PNA monomer with an Fmoc protecting group on the terminal amine, and a Bhoc protecting group on the modified base. It is used in the synthesis of peptide nucleic acids (PNAs) which are synthetic analogs of DNA and RNA. The Fmoc group allows for solid-phase synthesis, while the Bhoc group protects the base during chemical reactions.

CAT: BRP-02058

Molecular Formula: C40H36N4O7

Molecular Weight: 684.75

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: ZVLCJMSLDDKFKX-UHFFFAOYSA-N

CanonicalSMILES: O=C(O)CN(C(CC1=CC=C(NC(OC(C2=CC=CC=C2)C3=CC=CC=C3)=O)N=C1)=O)CCNC(OCC4C5=C(C=CC=C5)C6=C4C=CC=C6)=O

IUPAC Name: N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(6-(((benzhydryloxy)carbonyl)amino)pyridin-3-yl)acetyl)glycine

InChI: InChI=1S/C40H36N4O7/c45-36(23-27-19-20-35(42-24-27)43-40(49)51-38(28-11-3-1-4-12-28)29-13-5-2-6-14-29)44(25-37(46)47)22-21-41-39(48)50-26-34-32-17-9-7-15-30(32)31-16-8-10-18-33(31)34/h1-20,24,34,38H,21-23,25-26H2,(H,41,48)(H,46,47)(H,42,43,49)

Fmoc-PNA-M(Boc)-OH

Description: Fmoc-PNA-M(Boc)-OH is a PNA monomer with an Fmoc protecting group on the terminal amine and a Boc protecting group on the modified base. It is used in the synthesis of peptide nucleic acids (PNAs). The Fmoc group facilitates solid-phase synthesis by protecting the amine group, while the Boc group protects the base during chemical reactions.

CAT: BRP-02059

CAS: 1417611-27-8

Molecular Formula: C31H34N4O7

Molecular Weight: 574.62

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.308±0.06 g/cm3

Boiling Point: 781.3±60.0 °C at 760 mmHg

InChIKey: KKGJHNNYUDROSA-UHFFFAOYSA-N

CanonicalSMILES: CC(C)(C)OC(=O)NC1=NC=C(C=C1)CC(=O)N(CCNC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)CC(=O)O

IUPAC Name: 2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl-[2-[6-[(2-methylpropan-2-yl)oxycarbonylamino]pyridin-3-yl]acetyl]amino]acetic acid

InChI: InChI=1S/C31H34N4O7/c1-31(2,3)42-30(40)34-26-13-12-20(17-33-26)16-27(36)35(18-28(37)38)15-14-32-29(39)41-19-25-23-10-6-4-8-21(23)22-9-5-7-11-24(22)25/h4-13,17,25H,14-16,18-19H2,1-3H3,(H,32,39)(H,37,38)(H,33,34,40)

Synonyms: 2-(N-(2-(Fmoc)ethyl)-2-(6-(tert-butoxycarbonylamino)pyridin-3-yl)acetamido)acetic acid; N-[2-[6-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-pyridinyl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]glycine; N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(6-((tert-butoxycarbonyl)amino)pyridin-3-yl)acetyl)glycine

Fmoc-PNA-J(Bhoc)-OH

Description: Fmoc-PNA-J(Bhoc)-OH is a PNA monomer used in the synthesis of peptide nucleic acids (PNAs). It features an Fmoc (9-fluorenylmethyloxycarbonyl) protecting group on the terminal amine and a Bhoc (benzyloxycarbonyl) protecting group on the modified base J. These protecting groups facilitate solid-phase synthesis, ensuring the integrity of the monomer and preventing unwanted side reactions during the assembly of PNA sequences.

CAT: BRP-02060

Molecular Formula: C39H35N5O8

Molecular Weight: 701.74

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: AXTIXKVVQRPTAF-UHFFFAOYSA-N

CanonicalSMILES: O=C(O)CN(CCNC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O)C(CC4=CN=C(NC(OC(C5=CC=CC=C5)C6=CC=CC=C6)=O)NC4=O)=O

IUPAC Name: N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2-(((benzhydryloxy)carbonyl)amino)-6-oxo-1,6-dihydropyrimidin-5-yl)acetyl)glycine

InChI: InChI=1S/C39H35N5O8/c45-33(21-27-22-41-37(42-36(27)48)43-39(50)52-35(25-11-3-1-4-12-25)26-13-5-2-6-14-26)44(23-34(46)47)20-19-40-38(49)51-24-32-30-17-9-7-15-28(30)29-16-8-10-18-31(29)32/h1-18,22,32,35H,19-21,23-24H2,(H,40,49)(H,46,47)(H2,41,42,43,48,50)

Fmoc-PNA-D(tetraBhoc)-OH

Description: Fmoc-PNA-D(tetraBhoc)-OH is a peptide nucleic acid (PNA) monomer used in the synthesis of PNAs. It features an Fmoc (9-fluorenylmethyloxycarbonyl) protecting group on the terminal amine and tetraBhoc (tetra benzyloxycarbonyl) protecting groups on the modified base D. These protecting groups are essential for solid-phase synthesis, ensuring that the monomer remains stable and reactive only at the desired stages of the assembly process. This monomer is particularly useful for creating PNAs with specific binding properties and enhanced stability.

CAT: BRP-02061

Molecular Formula: C82H66N8O13

Molecular Weight: 1371.47

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: JQBRHDKMTRBGAE-UHFFFAOYSA-N

CanonicalSMILES: O=C(O)CN(CCNC(OCC1C2=C(C=CC=C2)C3=C1C=CC=C3)=O)C(CN4C=NC5=C4N=C(N(C(OC(C6=CC=CC=C6)C7=CC=CC=C7)=O)C(OC(C8=CC=CC=C8)C9=CC=CC=C9)=O)N=C5N(C(OC(C%10=CC=CC=C%10)C%11=CC=CC=C%11)=O)C(OC(C%12=CC=CC=C%12)C%13=CC=CC=C%13)=O)=O

IUPAC Name: N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2,6-bis(bis((benzhydryloxy)carbonyl)amino)-9H-purin-9-yl)acetyl)glycine

InChI: InChI=1S/C82H66N8O13/c91-68(87(52-69(92)93)50-49-83-78(94)99-53-67-65-47-27-25-45-63(65)64-46-26-28-48-66(64)67)51-88-54-84-70-75(88)85-77(90(81(97)102-73(59-37-17-5-18-38-59)60-39-19-6-20-40-60)82(98)103-74(61-41-21-7-22-42-61)62-43-23-8-24-44-62)86-76(70)89(79(95)100-71(55-29-9-1-10-30-55)56-31-11-2-12-32-56)80(96)101-72(57-33-13-3-14-34-57)58-35-15-4-16-36-58/h1-48,54,67,71-74H,49-53H2,(H,83,94)(H,92,93)

Fmoc-PNA-D(tetraBoc)-OH

Description: Fmoc-PNA-D(tetraBoc)-OH is a peptide nucleic acid (PNA) monomer used in the synthesis of PNA oligomers. It features an Fmoc (9-fluorenylmethyloxycarbonyl) protecting group on the terminal amine and tetraBoc (tetra tert-butoxycarbonyl) protecting groups on the modified base D. These protecting groups help maintain the integrity of the monomer during the solid-phase synthesis process, allowing for precise and controlled assembly of PNA sequences. This monomer is valuable for creating PNAs with tailored binding characteristics and increased stability for various biochemical applications.

CAT: BRP-02062

CAS: 2101661-88-3

Molecular Formula: C46H58N8O13

Molecular Weight: 931.00

Purity: ≥95%

Appearance: White to Light Beige Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C under inert atmosphere

Density: 1.30±0.1 g/cm3

Melting Point: 135-140°C

Boiling Point: 402.2±55.0°C (Predicted)

InChIKey: FNWBHNGZUCVYGL-UHFFFAOYSA-N

Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)

CanonicalSMILES: CC(C)(C)OC(=O)N(C1=NC(=NC2=C1N=CN2CC(=O)N(CCNC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)CC(=O)O)N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C

IUPAC Name: 2-[[2-[2,6-bis[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]purin-9-yl]acetyl]-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]amino]acetic acid

InChI: InChI=1S/C46H58N8O13/c1-43(2,3)64-39(59)53(40(60)65-44(4,5)6)36-34-35(49-37(50-36)54(41(61)66-45(7,8)9)42(62)67-46(10,11)12)52(26-48-34)23-32(55)51(24-33(56)57)22-21-47-38(58)63-25-31-29-19-15-13-17-27(29)28-18-14-16-20-30(28)31/h13-20,26,31H,21-25H2,1-12H3,(H,47,58)(H,56,57)

Synonyms: 2-(N-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(2,6-bis(bis(tert-butoxycarbonyl)amino)-9H-purin-9-yl)acetamido)acetic acid; N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2,6-bis(bis(tert-butoxycarbonyl)amino)-9H-purin-9-yl)acetyl)glycine; 2-{2-[2,6-bis({bis[(tert-butoxy)carbonyl]amino})-9H-purin-9-yl]-N-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)ethyl]acetamido}acetic acid

Boc-PNA-D(tetraZ)-OH

Description: Boc-PNA-D(tetraZ)-OH is a peptide nucleic acid (PNA) monomer used in the synthesis of PNA oligomers. It features a Boc (tert-butoxycarbonyl) protecting group on the terminal amine and tetraZ (tetra benzyloxycarbonyl) protecting groups on the modified base D. These protecting groups are utilized to protect reactive sites during the solid-phase synthesis, ensuring accurate assembly of PNA sequences. This monomer is important for constructing PNAs with specific binding properties and enhanced stability for various biochemical and biomedical applications.

CAT: BRP-02063

Molecular Formula: C48H48N8O13

Molecular Weight: 944.96

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: XREWKMOLHCLRJZ-UHFFFAOYSA-N

CanonicalSMILES: O=C(O)CN(CCNC(OC(C)(C)C)=O)C(CN1C=NC2=C1N=C(N(C(OCC3=CC=CC=C3)=O)C(OCC4=CC=CC=C4)=O)N=C2N(C(OCC5=CC=CC=C5)=O)C(OCC6=CC=CC=C6)=O)=O

IUPAC Name: N-(2-(2,6-bis(bis((benzyloxy)carbonyl)amino)-9H-purin-9-yl)acetyl)-N-(2-((tert-butoxycarbonyl)amino)ethyl)glycine

InChI: InChI=1S/C48H48N8O13/c1-48(2,3)69-43(60)49-24-25-53(27-38(58)59)37(57)26-54-32-50-39-40(54)51-42(56(46(63)67-30-35-20-12-6-13-21-35)47(64)68-31-36-22-14-7-15-23-36)52-41(39)55(44(61)65-28-33-16-8-4-9-17-33)45(62)66-29-34-18-10-5-11-19-34/h4-23,32H,24-31H2,1-3H3,(H,49,60)(H,58,59)

ENA-T-Phosphoramidite

Description: ENA-T-Phosphoramidite is a specialized reagent used in oligonucleotide synthesis. This phosphoramidite derivative allows for the introduction of modified nucleotide sequences into synthetic oligonucleotides, facilitating various research and biotechnological applications.

CAT: BRP-02064

CAS: 287737-40-0

Molecular Formula: C42H51N4O9P

Molecular Weight: 786.86

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: BCXPUDBJUMTTSQ-RWDMRMDHSA-N

CanonicalSMILES: CC1=CN(C(=O)NC1=O)C2C3C(C(O2)(CCO3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)OP(N(C(C)C)C(C)C)OCCC#N

IUPAC Name: 3-[[(1R,5R,7R,8S)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C42H51N4O9P/c1-28(2)46(29(3)4)56(53-24-11-23-43)55-37-36-39(45-26-30(5)38(47)44-40(45)48)54-41(37,22-25-51-36)27-52-42(31-12-9-8-10-13-31,32-14-18-34(49-6)19-15-32)33-16-20-35(50-7)21-17-33/h8-10,12-21,26,28-29,36-37,39H,11,22,24-25,27H2,1-7H3,(H,44,47,48)/t36-,37+,39-,41-,56?/m1/s1

Synonyms: ENA-T-CE-Phosphoramidite; 2,4(1H,3H)-Pyrimidinedione, 1-[2,6-anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-5-methyl-; 1-[2,6-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-5-methyl-2,4(1H,3H)-pyrimidinedione; ENA-5-Me-U-Phosphoramidite

5'-O-DMT-2'-O-TBDMS-5-Methy-L-Uridine 3'-CE phosphoramidite

Description: 5'-O-DMT-2'-O-TBDMS-5-Methyl-L-Uridine 3'-CE phosphoramidite is a specialized phosphoramidite used in the synthesis of oligonucleotides. It contains a dimethoxytrityl (DMT) group at the 5'-hydroxyl position, a tert-butyldimethylsilyl (TBDMS) group at the 2'-hydroxyl position, and a cyanoethyl (CE) group attached to the phosphoramidite. This reagent incorporates the 5-methyl modification on the uridine base, specifically in the L-configuration, into oligonucleotides, which is important for enhancing the stability and binding properties of the synthesized strands, making it useful in various genetic and therapeutic applications.

CAT: BRP-02151

Molecular Formula: C46H63N4O9PSi

Molecular Weight: 875.09

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: KYRSLFQMFXXGLW-PKLCMXGVSA-N

CanonicalSMILES: CC1=CN(C(=O)NC1=O)C2C(C(C(O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OP(N(C(C)C)C(C)C)OCCC#N)O[Si](C)(C)C(C)(C)C

IUPAC Name: 3-[[(2S,3S,4S,5S)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C46H63N4O9PSi/c1-31(2)50(32(3)4)60(56-28-16-27-47)58-40-39(57-43(41(40)59-61(11,12)45(6,7)8)49-29-33(5)42(51)48-44(49)52)30-55-46(34-17-14-13-15-18-34,35-19-23-37(53-9)24-20-35)36-21-25-38(54-10)26-22-36/h13-15,17-26,29,31-32,39-41,43H,16,28,30H2,1-12H3,(H,48,51,52)/t39-,40-,41-,43-,60?/m0/s1

Synonyms: L-Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-5-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]; 5-Methyl-5'-O-(4,4'-Dimethoxytrityl)-2'-O-(t-butyldimethylsilyl)-L-uridine-3'-cyanoethyl phosphoramidite; 5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-3'-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]-2'-O-[dimethyl(2-methyl-2-propanyl)silyl]-5-methyl-L-uridine; DMT-2'-O-TBDMS-5-Me-L-rU Phosphoramidite; 5'-O-DMT-2'-O-TBDMS-L-rT Phosphoramidite; 5'-O-DMT-2'-O-TBDMS-L-MeU 3'-CE-Phosphoramidite; 2'-O-tert-Butyldimethylsilyl-5'-O-DMT-L-5-methyluridine 3'-CE phosphoramidite; 5'-O-DMTr-2'-O-TBDMS-β-L-T-3'-CE-Phosphoramidite

5'-O-DMT-N4-Acetyl-2'-fluoro-2'-deoxy-L-cytidine 3'-CE phosphoramidite

Description: 5'-O-DMT-N4-Acetyl-2'-fluoro-2'-deoxy-L-cytidine 3'-CE phosphoramidite is a modified phosphoramidite designed for efficient and controlled synthesis of RNA and DNA oligonucleotides. The protective groups and modifications, such as 5'-O-DMTr, N4-acetyl, and 2'-fluoro-2'-deoxy, enhance the stability of the resulting nucleic acids and facilitate their incorporation into nucleic acid chains during solid-phase synthesis. This compound is crucial in the production of antisense oligonucleotides, siRNA, probes, and primers, providing enhanced resistance to enzymatic degradation and improved performance in various applications.

CAT: BRP-02152

CAS: 856888-81-8

Molecular Formula: C41H49FN5O8P

Molecular Weight: 789.83

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: CNFKJHKDSRXNFL-NYKPPYOCSA-N

CanonicalSMILES: N#CCCOP(OC1C(F)C(OC1COC(C=2C=CC=CC2)(C3=CC=C(OC)C=C3)C4=CC=C(OC)C=C4)N5C=CC(=NC5=O)NC(=O)C)N(C(C)C)C(C)C

IUPAC Name: N-[1-[(2S,3S,4S,5S)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide

InChI: InChI=1S/C41H49FN5O8P/c1-27(2)47(28(3)4)56(53-25-11-23-43)55-38-35(54-39(37(38)42)46-24-22-36(44-29(5)48)45-40(46)49)26-52-41(30-12-9-8-10-13-30,31-14-18-33(50-6)19-15-31)32-16-20-34(51-7)21-17-32/h8-10,12-22,24,27-28,35,37-39H,11,25-26H2,1-7H3,(H,44,45,48,49)/t35-,37-,38-,39-,56?/m0/s1

Synonyms: N-[1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-deoxy-2-fluoro-β-L-ribofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]acetamide; (2S,3S,4S,5S)-5-(4-acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite; N4-Acetyl-2'-deoxy-5'-O-DMT-2'-fluoro-L-cytidine 3'-CE phosphoramidite; 2'-F-Ac-L-dC CE phosphoramide; DMT-2'-F-L-dC(Ac)-CE Phosphoramidite; N4-Acetyl-5'-O-(4,4'-dimethoxytrityl)-2'-fluoro-2'-deoxy-L-cytidine-3'-CE-Phosphoramidite; 2'-Fluoro-2'-deoxy-L-Cytidine (n-ac) CED Phosphoramidite; 5'-O-DMT-2'-F-L-dC(Ac) 3'-CE phosphoramidite

5'-O-DMT-N4-Benzoyl-2'-deoxy-2'-fluoro-cytidine phosphoramidite (BRP-02161)

Description: A novel nucleoside phosphoramidite with anticancer and antiviral properties.

CAT: BRP-02161

CAS: 161442-19-9

Molecular Formula: C46H51FN5O8P

Molecular Weight: 851.90

Purity: ≥98% by HPLC

Appearance: White to light yellow solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: CKKJPMGSTGVCJJ-GNUWXFRUSA-N

Solubility: Soluble in DMSO

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1F)N2C=CC(=NC2=O)NC(=O)C3=CC=CC=C3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC

IUPAC Name: N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide

InChI: InChI=1S/C46H51FN5O8P/c1-31(2)52(32(3)4)61(58-29-13-27-48)60-42-39(59-44(41(42)47)51-28-26-40(50-45(51)54)49-43(53)33-14-9-7-10-15-33)30-57-46(34-16-11-8-12-17-34,35-18-22-37(55-5)23-19-35)36-20-24-38(56-6)25-21-36/h7-12,14-26,28,31-32,39,41-42,44H,13,29-30H2,1-6H3,(H,49,50,53,54)/t39-,41-,42-,44-,61?/m1/s1

Synonyms: 2'-Fluoro-N4-benzoyl-5'-O-DMT-2'-deoxycytidine-3'-ce-phosphoramidite; Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]; 2'-F-Bz-dC Phosphoramidite; N4-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-cytidine phosphoramidite; N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluorocytidine 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]

N4-Benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-DMT-cytidine 3'-CE phosphoramidite (BRP-02162)

Description: N4-Benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-DMT-cytidine 3'-CE phosphoramidite is an indispensable biomolecule, finding profound applications within the intricate synthesis of bespoke nucleotides, thus aiding in genetic investigations.

CAT: BRP-02162

CAS: 118380-84-0

Molecular Formula: C52H66N5O9PSi

Molecular Weight: 964.19

Appearance: White to off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

InChIKey: VWNXEDLLHIFAOL-YOVDOAOFSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1O[Si](C)(C)C(C)(C)C)N2C=CC(=NC2=O)NC(=O)C3=CC=CC=C3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC

IUPAC Name: N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide

InChI: InChI=1S/C52H66N5O9PSi/c1-36(2)57(37(3)4)67(63-34-18-32-53)65-46-44(35-62-52(39-21-16-13-17-22-39,40-23-27-42(60-8)28-24-40)41-25-29-43(61-9)30-26-41)64-49(47(46)66-68(10,11)51(5,6)7)56-33-31-45(55-50(56)59)54-48(58)38-19-14-12-15-20-38/h12-17,19-31,33,36-37,44,46-47,49H,18,34-35H2,1-11H3,(H,54,55,58,59)/t44-,46-,47-,49-,67?/m1/s1

Synonyms: Bz-rC Phosphoramidite; N-Bz-2'-O-TBDMS-5'-DMT-cytidine 3'-CE phosphoramidite; Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-, 3'-[2-cyanoethylbis(1-methylethyl)phosphoramidite]; N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-O-tert-butyldimethylsilyl)cytidine 3'-O-[O-(2-cyanoethyl)-N,N'-diisopropylphosphoramidite]; 5'-DMT-2'-TBDMS-N4-Bz-rC phosphoramidite; 5'-O-DMT-2'-O-TBDMS-rC (Bz) phosphoramidite; 5'-O-DMT-2'-O-TBDMS-rC(Bz) 3'-CE phosphoramidite

2'-O-Methyl-rG(N-Ac) phosphoramidite (BRP-02166)

Description: 2'-O-Methyl-rG(N-Ac) phosphoramidite is an anticancer agent with antiviral and antiparasitic activities. 2'-O-Methyl-rG(N-Ac) phosphoramidite is a modified guanosine phosphoramidite used in oligonucleotide synthesis. It features a 2'-O-methyl group, which enhances the stability of the oligonucleotide by increasing resistance to nucleases and improving binding affinity. The N-Ac (N-acetyl) group protects the amino group of the guanine base during synthesis. This reagent is particularly useful for synthesizing RNA molecules with increased stability and improved hybridization properties, making it valuable for applications in molecular biology, diagnostics, and therapeutic development.

CAT: BRP-02166

CAS: 909033-40-5

Molecular Formula: C43H52N7O9P

Molecular Weight: 841.89

Purity: ≥98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: FBABQKPBRXEHBT-USUFPPIWSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1OC)N2C=NC3=C2N=C(NC3=O)NC(=O)C)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC

IUPAC Name: N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-methoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]acetamide

InChI: InChI=1S/C43H52N7O9P/c1-27(2)50(28(3)4)60(57-24-12-23-44)59-37-35(58-41(38(37)55-8)49-26-45-36-39(49)47-42(46-29(5)51)48-40(36)52)25-56-43(30-13-10-9-11-14-30,31-15-19-33(53-6)20-16-31)32-17-21-34(54-7)22-18-32/h9-11,13-22,26-28,35,37-38,41H,12,24-25H2,1-8H3,(H2,46,47,48,51,52)/t35-,37-,38-,41-,60?/m1/s1

Synonyms: Ac-2'-OMe-rG Phosphoramidite; N-Acetyl-5'-O-(4,4-dimethoxytrityl)-2'-O-methylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite; 5'-O-DMT-2'-O-Me-rG(Ac)-3'-CE phosphoramidite; 5'-O-DMT-2'-O-Me-rG(N-Ac)-3'-CED; 5'-DMT-2'-OMe-rG(N-Ac) Phosphoramidite; Guanosine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite]

1-(2'-Deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)uracil 3'-CE-phosphoramidite (BRP-02167)

Description: 1-(2'-Deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)uracil 3'-CE-phosphoramidite is a novel nucleotide monophosphate with antiviral and anticancer properties.

CAT: BRP-02167

CAS: 1190089-70-3

Molecular Formula: C39H46FN4O8P

Molecular Weight: 748.78

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: HQHQPAYRJJMYQX-CPBIVIIKSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1F)N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC

IUPAC Name: 3-[[(2R,3R,4S,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(2,4-dioxopyrimidin-1-yl)-4-fluorooxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C39H46FN4O8P/c1-26(2)44(27(3)4)53(50-24-10-22-41)52-36-33(51-37(35(36)40)43-23-21-34(45)42-38(43)46)25-49-39(28-11-8-7-9-12-28,29-13-17-31(47-5)18-14-29)30-15-19-32(48-6)20-16-30/h7-9,11-21,23,26-27,33,35-37H,10,24-25H2,1-6H3,(H,42,45,46)/t33-,35+,36-,37-,53?/m1/s1

Synonyms: 2'-Fluoro-2'-deoxy-ara-U-3'-phosphoramidite; 5'-O-(4,4'-Dimethoxytrityl)-2'-deoxy-2'-fluoro-b-D-arabinouridine-3'-CEN-phosphoramidite; 5'-O-DMT-2'-F-2'-arabinofuranosyl-deoxyuridine 3'-CE phosphoramidite; 2,4(1H,3H)-Pyrimidinedione, 1-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-deoxy-2-fluoro-α-D-arabinofuranosyl]-; 2'-ara-2'-F-2'-dU Phosphoramidite; 2'-F-U-ANA-CE Phosphoramidite

5'-O-DMT-3'-O-tert-Butyldimethylsilyl-uridine-2'-CE phosphoramidite (BRP-02169)

Description: 5'-O-DMT-3'-O-tert-Butyldimethylsilyl-uridine-2'-CE phosphoramidite is a phosphoramidite reagent used in the synthesis of oligonucleotides. It features a dimethoxytrityl (DMT) protecting group at the 5'-hydroxyl position, a tert-butyldimethylsilyl (TBDMS) protecting group at the 3'-hydroxyl position, and a cyanoethyl (CE) protecting group on the phosphoramidite at the 2' position. These protective groups ensure efficient incorporation of uridine into oligonucleotides while enhancing the stability and accuracy of synthesis. This reagent is important for creating modified oligonucleotides for research and therapeutic applications.

CAT: BRP-02169

CAS: 129451-77-0

Molecular Formula: C45H61N4O9PSi

Molecular Weight: 861.05

Purity: ≥97% by HPLC

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: UZVSHRLVIXPYEZ-ZMHKPELYSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(C(OC1N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O[Si](C)(C)C(C)(C)C

IUPAC Name: 3-[[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxy-2-(2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C45H61N4O9PSi/c1-31(2)49(32(3)4)59(55-29-15-27-46)57-41-40(58-60(10,11)44(5,6)7)38(56-42(41)48-28-26-39(50)47-43(48)51)30-54-45(33-16-13-12-14-17-33,34-18-22-36(52-8)23-19-34)35-20-24-37(53-9)25-21-35/h12-14,16-26,28,31-32,38,40-42H,15,29-30H2,1-11H3,(H,47,50,51)/t38-,40-,41-,42-,59?/m1/s1

Synonyms: 3'-O-tert-Butyldimethylsilyl-5'-O-DMT-uridine 2'-CE phosphoramidite; 3'-TBDMS-rU Phosphoramidite; 5-O-(4,4'-dimethoxytrityl)-2-O-(diisopropylamino-2-cyanoethoxyphosphanyl)-3-O-(tert-butyl-dimethyl-silyl)-1-deoxy-1-uracil-1-yl-beta-D-ribo-pentofuranose; Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-, 2'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]; 3'-OTBS U 2'-amidite; 3'-O-TBDMS-5'-O-DMT-rU CED phosphoramidite; DMT-3'-O-TBDMS-U-2'-CE-Phosphoramidite

2'-Fluoro-2'-deoxy-ara-C(Bz)-3'-phosphoramidite (BRP-02171)

Description: 2'-Fluoro-2'-deoxy-ara-C(Bz)-3'-phosphoramidite is a modified phosphoramidite used in the synthesis of oligonucleotides. This compound features a 2'-fluoro and 2'-deoxy modification on the arabinose sugar, a benzoyl (Bz) protective group on the nucleobase cytosine, and a phosphoramidite group at the 3' position. These modifications enhance the chemical stability and binding affinity of the resulting oligonucleotides, making them useful for applications in molecular biology, diagnostics, and therapeutic development.

CAT: BRP-02171

CAS: 1404463-12-2

Molecular Formula: C46H51FN5O8P

Molecular Weight: 851.90

Purity: ≥95%

Appearance: White to Off-white Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

Boiling Point: 856.5±75.0°C at 760 mmHg

InChIKey: CKKJPMGSTGVCJJ-OEJVQKCDSA-N

Solubility: Soluble in DMSO

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1F)N2C=CC(=NC2=O)NC(=O)C3=CC=CC=C3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC

IUPAC Name: N-[1-[(2R,3S,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide

Synonyms: N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-2'-fluoro-b-D-arabinocytidine-3'-CED-phosphoramidite; N4-Benzoyl-2'-fluoro-5'-O-DMT-2'-arabinofuranosyl-deoxycytidine phosphoramidite; 4-(Benzoylimino)-1-{5-O-[bis(4-methoxyphenyl)(phenyl)methyl]-3-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]-2-deoxy-2-fluoro-β-D-arabinofuranosyl}-1,4-dihydro-2-pyrimidinol; N4-Benzoyl-1-(2'-deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)cytidine 3'-CE-phosphoramidite; 5'-O-DMTr-2'-ara-F-C(Bz)-3'-CE-Phosphoramidite; 2'-F-2'-ara-Bz-dC Phosphoramidite; 2'-F-dC(Bz)-ANA-CE Phosphoramidite; 2'-F-2'-ara-N4-Bz-dC phosphoramidite

9-(2'-Deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)-N2-isobutyrylguanine 3'-CE phosphoramidite (BRP-02172)

Description: The 9-(2'-Deoxy-5'-O-DMT-2'-fluoro-beta-D-arabinofuranosyl)-N2-isobutyrylguanine 3'-CE phosphoramidite has been proven effective against cancer.

CAT: BRP-02172

CAS: 1404463-20-2

Molecular Formula: C44H53FN7O8P

Molecular Weight: 857.93

Purity: ≥97% by HPLC

Appearance: White to Off-white Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: KJFUMXZZVYMQEU-SJIRJWTBSA-N

CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)OP(N(C(C)C)C(C)C)OCCC#N)F

IUPAC Name: N-[9-[(2R,3S,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide

InChI: InChI=1S/C44H53FN7O8P/c1-27(2)40(53)49-43-48-39-37(41(54)50-43)47-26-51(39)42-36(45)38(60-61(58-24-12-23-46)52(28(3)4)29(5)6)35(59-42)25-57-44(30-13-10-9-11-14-30,31-15-19-33(55-7)20-16-31)32-17-21-34(56-8)22-18-32/h9-11,13-22,26-29,35-36,38,42H,12,24-25H2,1-8H3,(H2,48,49,50,53,54)/t35-,36+,38-,42-,61?/m1/s1

Synonyms: 5'-O-DMT-2'-fluoro-N2-isobutyryl-2'-arabinofuranosyl-deoxyguanosine 3'-CE phosphoramidite; 2'-F-2'-ara-N2-ibu-dG phosphoramidite; Propanamide, N-[9-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-deoxy-2-fluoro-β-D-arabinofuranosyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-2-methyl-; N2-iso-Butyroyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-fluoro-2'-arabinoguanosine-3'-CED-phosphoramidite; 9-{5-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-3-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]-2-deoxy-2-fluoro-β-D-arabinofuranosyl}-2-(isobutyrylamino)-1,9-dihydro-6H-purin-6-one

5'-O-DMT-3'-O-tert-Butyldimethylsilyl-N2-isobutyrylguanosine 2'-CE phosphoramidite (BRP-02175)

Description: 5'-O-DMT-3'-O-tert-Butyldimethylsilyl-N2-isobutyrylguanosine 2'-CE phosphoramidite is a specialized phosphoramidite used for the synthesis of oligonucleotides. It includes a 5'-dimethoxytrityl (DMT) group for 5'-hydroxyl protection, a 3'-tert-butyldimethylsilyl (TBDMS) group for 3'-hydroxyl protection, and an N2-isobutyryl group to protect the exocyclic amine of the guanine base. Additionally, it has a cyanoethyl (CE) group at the 2'-position of the phosphoramidite. These protective groups help facilitate efficient synthesis and stability of the oligonucleotides, making this compound valuable for research, diagnostic, and therapeutic applications.

CAT: BRP-02175

CAS: 1445905-51-0

Molecular Formula: C50H68N7O9PSi

Molecular Weight: 970.18

Purity: ≥95%

Appearance: White, off-white to faint yellow powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

InChIKey: JCCWPNDXSMAHGZ-FTZVBZPOSA-N

CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O[Si](C)(C)C(C)(C)C)OP(N(C(C)C)C(C)C)OCCC#N

IUPAC Name: N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxy-3-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide

InChI: InChI=1S/C50H68N7O9PSi/c1-32(2)45(58)54-48-53-44-41(46(59)55-48)52-31-56(44)47-43(65-67(63-29-17-28-51)57(33(3)4)34(5)6)42(66-68(12,13)49(7,8)9)40(64-47)30-62-50(35-18-15-14-16-19-35,36-20-24-38(60-10)25-21-36)37-22-26-39(61-11)27-23-37/h14-16,18-27,31-34,40,42-43,47H,17,29-30H2,1-13H3,(H2,53,54,55,58,59)/t40-,42-,43-,47-,67?/m1/s1

Synonyms: 3'-O-tert-Butyldimethylsilyl-5'-O-DMT-N2-isobutyrylguanosine 2'-CE phosphoramidite; (2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-2-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite; 3'-TBDMS-ibu-rG Phosphoramidite; 3'-O-TBDMS-5'-O-DMT-N2-iBu-rG CED phosphoramidite; 5'-O-DMTr-2'-O-TBDMS-L-G(iBu)-3'-CE-Phosphoramidite; N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-O-(t-butyl-dimethylsilyl)-L-guanosine-3'-cyanoethyl Phosphoramidite

N4-Bz-5'-O-DMTr-2'-O-Me-cytidine-3'-CED-phosphoramidite (BRP-02177)

Description: N4-Bz-5'-O-DMTr-2'-O-Me-cytidine-3'-CED-phosphoramidite is a modified phosphoramidite designed for use in the synthesis of stable and efficient oligonucleotides. Its protective groups and modifications enhance the stability of the resulting nucleic acids and facilitate their incorporation into nucleic acid chains during solid-phase synthesis. This compound is crucial in the production of antisense oligonucleotides, siRNA, probes, and primers, providing enhanced resistance to enzymatic degradation and improved performance in various applications.

CAT: BRP-02177

CAS: 110764-78-8

Molecular Formula: C47H54N5O9P

Molecular Weight: 863.93

Purity: ≥95%

Appearance: White Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: JFFSFQRVIPPCBC-VKBHKTMGSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1OC)N2C=CC(=NC2=O)NC(=O)C3=CC=CC=C3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC

IUPAC Name: N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide

InChI: InChI=1S/C47H54N5O9P/c1-32(2)52(33(3)4)62(59-30-14-28-48)61-42-40(60-45(43(42)57-7)51-29-27-41(50-46(51)54)49-44(53)34-15-10-8-11-16-34)31-58-47(35-17-12-9-13-18-35,36-19-23-38(55-5)24-20-36)37-21-25-39(56-6)26-22-37/h8-13,15-27,29,32-33,40,42-43,45H,14,30-31H2,1-7H3,(H,49,50,53,54)/t40-,42-,43-,45-,62?/m1/s1

Synonyms: N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-O-methycytidine-3'-O-[(2-cyanoethyl)-(N,N-diisopropyl)]phosphoramidite; 2'-O-Me-C(Bz)-3'-phosphoramidite; 2'-OMe-Bz-C Phosphoramidite; N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methylcytidine 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite]; N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-3'-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]-2'-O-methylcytidine; N4-Benzoyl-5'-O-DMT-2'-O-methylcytidine 3'-CE phosphoramidite

5'-O-DMT-2'-O-(2-methoxyethyl)uridine 3'-CE phosphoramidite (BRP-02178)

Description: 5'-O-DMT-2'-O-(2-methoxyethyl)uridine 3'-CE phosphoramidite is a building block for introducing uridine units into oligonucleotides.

CAT: BRP-02178

CAS: 163759-97-5

Molecular Formula: C42H53N4O10P

Molecular Weight: 804.86

Purity: ≥95%

Appearance: White to Off-white Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: ZLOKLUONKGURQI-UAQIPLLRSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1OCCOC)N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC

IUPAC Name: 3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(2,4-dioxopyrimidin-1-yl)-4-(2-methoxyethoxy)oxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C42H53N4O10P/c1-29(2)46(30(3)4)57(54-25-11-23-43)56-38-36(55-40(39(38)52-27-26-49-5)45-24-22-37(47)44-41(45)48)28-53-42(31-12-9-8-10-13-31,32-14-18-34(50-6)19-15-32)33-16-20-35(51-7)21-17-33/h8-10,12-22,24,29-30,36,38-40H,11,25-28H2,1-7H3,(H,44,47,48)/t36-,38-,39-,40-,57?/m1/s1

Synonyms: 2'-O-MOE-U-3'-phosphoramidite; 5'-O-DMTr-2'-O-(2-methoxyethyl)-uridine-3'-CED-phosphoramidite; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)uridine 3'-[2-cyanoethylbis(1-methylethyl)phosphoramidite]; 5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-3'-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]-2'-O-(2-methoxyethyl)uridine

5'-O-DMT-2'-O-tert-Butyldimethylsilyl-N6-methyl-adenosine 3'-CE phosphoramidite (BRP-02185)

Description: 5'-O-DMT-2'-O-tert-Butyldimethylsilyl-N6-methyl-adenosine 3'-CE phosphoramidite is a vital compound used in the biomedical industry for synthesizing RNA molecules. This phosphoramidite aids in the incorporation of modified adenosine bases during RNA synthesis, enabling researchers to study specific drug targets or diseases related to N6-methyladenosine methylation. By providing precise adenosine modifications, this product facilitates the investigation of gene expression and regulatory mechanisms, leading to potential breakthroughs in drug discovery and disease understanding.

CAT: BRP-02185

CAS: 588698-79-7

Molecular Formula: C47H64N7O7PSi

Molecular Weight: 898.11

Purity: ≥98% by HPLC

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Boiling Point: 859.0±75.0°C (Predicted)

InChIKey: GPLFLRPEMRRWIR-UTZPQXNGSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1O[Si](C)(C)C(C)(C)C)N2C=NC3=C(N=CN=C32)NC)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC

IUPAC Name: 3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxy-5-[6-(methylamino)purin-9-yl]oxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C47H64N7O7PSi/c1-32(2)54(33(3)4)62(58-28-16-27-48)60-41-39(59-45(42(41)61-63(11,12)46(5,6)7)53-31-52-40-43(49-8)50-30-51-44(40)53)29-57-47(34-17-14-13-15-18-34,35-19-23-37(55-9)24-20-35)36-21-25-38(56-10)26-22-36/h13-15,17-26,30-33,39,41-42,45H,16,28-29H2,1-12H3,(H,49,50,51)/t39-,41-,42-,45-,62?/m1/s1

Synonyms: Adenosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-N-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]; N6-Me-rA phosphoramidite; 5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-3'-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]-2'-O-[dimethyl(2-methyl-2-propanyl)silyl]-N-methyladenosine; N6-Me-DMT-2'-O-TBDMS-A-CE Phosphoramidite; N6-Methyl-5'-O-(4,4'-dimethoxytrityl)-2'-O-(t-butyl-dimethylsilyl)-adenosine-3'-cyanoethyl-Phosphoramidite; 5'-O-DMT-2'-O-TBDMS-N6-methyl-Adenosine 3'-CE phosphoramidite; DMTr-2'-O-TBDMS-N6-Me-rA-3'-CE-Phosphoramidite

Fmoc-PNA-M(Bhoc)-OH

Fmoc-PNA-M(Boc)-OH

Fmoc-PNA-J(Bhoc)-OH

Fmoc-PNA-D(tetraBhoc)-OH

Fmoc-PNA-D(tetraBoc)-OH

Boc-PNA-D(tetraZ)-OH

ENA-T-Phosphoramidite

5'-O-DMT-2'-O-TBDMS-5-Methy-L-Uridine 3'-CE phosphoramidite

5'-O-DMT-N4-Acetyl-2'-fluoro-2'-deoxy-L-cytidine 3'-CE phosphoramidite

5'-O-DMT-N4-Benzoyl-2'-deoxy-2'-fluoro-cytidine phosphoramidite (BRP-02161)

N4-Benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-DMT-cytidine 3'-CE phosphoramidite (BRP-02162)

2'-O-Methyl-rG(N-Ac) phosphoramidite (BRP-02166)

1-(2'-Deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)uracil 3'-CE-phosphoramidite (BRP-02167)

5'-O-DMT-3'-O-tert-Butyldimethylsilyl-uridine-2'-CE phosphoramidite (BRP-02169)

2'-Fluoro-2'-deoxy-ara-C(Bz)-3'-phosphoramidite (BRP-02171)

9-(2'-Deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)-N2-isobutyrylguanine 3'-CE phosphoramidite (BRP-02172)

5'-O-DMT-3'-O-tert-Butyldimethylsilyl-N2-isobutyrylguanosine 2'-CE phosphoramidite (BRP-02175)

N4-Bz-5'-O-DMTr-2'-O-Me-cytidine-3'-CED-phosphoramidite (BRP-02177)

5'-O-DMT-2'-O-(2-methoxyethyl)uridine 3'-CE phosphoramidite (BRP-02178)

5'-O-DMT-2'-O-tert-Butyldimethylsilyl-N6-methyl-adenosine 3'-CE phosphoramidite (BRP-02185)

Our Products

Liposome Products

MicroRNA Products

mRNA Products

siRNA Products

RNA Synthesis Reagents

Cap Analogs

CPGs for Oligo Synthesis

Nucleosides

Nucleotides

Phosphoramidites